Chinook Therapeutics

Canada
Sydney Forks, Nova Scotia, Canada, V5T 4T5

Company profile

Chinook Therapeutics company profile

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science. The company focuses on developing precision medicines for kidney diseases. Its services offers utilization of novel translational platforms and patient stratification tools, and emergence of accelerated regulatory pathways based on surrogate endpoints.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Postal code
V5T 4T5
Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
4
Total equity funding
$276M
Last funding
Post IPO Equity / $105M / 2022-05-24
Last equity funding
Post IPO Equity / $105M
Investors
12
Lead investors
1
Founders
1
Articles
57
Exited on
2020-10-05

Founders and investors

Founders

Ross Haghighat

Lead investors

Versant Ventures

Investors

Ally Bridge GroupJanus Henderson InvestorsNorthleaf Capital PartnersOrbiMedSamsara BioCapital